On Our Radar
Spry’s latest poll reveals where Tennessee Republicans stand on key national and state priorities. At the federal level, respondents strongly back Trump’s 2025 agenda while also voicing overwhelming support DOGE to curb waste and fraud. However, views are split on Governor Bill Lee’s decision to use debt to fund road projects. Notably, infrastructure topped the list of areas that GOP voters believe were underfunded in the 2023–2024 state budget, signaling concern over long-term investment strategy despite the divided opinion on financing through debt.
Novo Nordisk, a pioneer in GLP-1–based obesity treatments, is expanding its pipeline with a $200 million licensing deal for UBT251, a next-generation “triple agonist” drug from China-based United Laboratories. GLP-1 drugs like Novo’s Wegovy have transformed obesity care, but rising competition has pushed Novo to diversify. UBT251 has shown promising early results, including 15.1% average weight loss in 12 weeks during a Phase 1 trial. The deal marks a strategic move to maintain Novo’s lead in a rapidly evolving and highly competitive market.
Big congratulations to our Co-founder and Managing Partner, Clint Brewer, on being named to The Nashville Post’s In Charge 2025: Marketing list—marking his sixth consecutive year on the list. Clint’s sharp vision and steady leadership inspire everything we do at Imperium, and we’re lucky to have him at the helm.
Garden & Gun has once again launched its annual March Madness–style bracket, pitting 32 of the South’s most iconic steakhouses against each other in a sizzling showdown. This year, Sperry’s in Belle Meade (a longtime favorite of Clint and Josh) has carved its way into the Sweet 16. Cast your vote and help crown the ultimate Southern steakhouse.
Brad Smith, from the DOGE team, recently discussed the organization's commitment to ensuring that the United States remains a global leader in biomedical research while simultaneously safeguarding Medicare and Medicaid. Smith emphasized the importance of balancing scientific advancement with the protection of critical healthcare programs. By prioritizing both innovation and healthcare security, DOGE aims to sustain public trust while driving medical breakthroughs.
Yesterday’s TBPN podcast featured multiple private defense tech startup founders who are shaping the future of national security. These leaders are building fast, innovating boldly, and proving that private capital can drive serious impact in a historically slow-moving industry. Their insights reveal what it takes to win contracts, scale tech, and navigate the defense ecosystem. Give this Defense Tech Day episode a listen if you care about where defense is headed.
Other Reading
No Finishers in Tennessee’s Notorious Ultra-Marathon (Sports Illustrated)
Everything is national security now (Semafor)
Most AI value will come from broad automation, not from R&D (Epoch AI)
Community Notes on X and Meta Can’t Save Social Media From Itself (Bloomberg)
Jonathan Haidt: Parents are coming for the social media companies (Financial Times)






